In patient-derived T-ALL xenografts (PD T-ALL) the drug induced cell death and activated AMPK as well as EIF2A phosphorylation (Fig. 3c and d), demonstrating that this molecular event is not limited to cell line models but is also present in primary leukemia cells. This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.